Recherche - Archive ouverte HAL

113 résultats

	Pour les 113 documents Envoyer sur ORCID RSS ATOM Exporter BibTeX XML-TEI CSV RTF EndNote PDF HTML Export avancé	Page : Page précédente 1 2 3 4 Page suivante	triés par Pertinence Auteur A→Z Auteur Z→A Titre A→Z Titre Z→A Date de publication croissante Date de publication décroissante Date de dépôt croissante Date de dépôt décroissante

		Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. Stéphanie Sungalee , Emilie Mamessier , Ester Morgado , Emilie Grégoire , Philip Z Brohawn , et al. Journal of Clinical Investigation, 2014, 124 (12), pp.72415. ⟨10.1172/JCI72415⟩ Article dans une revue hal-01083543v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature Francois Bertucci , Vincent Niziers , Alexandre de Nonneville , Pascal Finetti , Léna Mescam , et al. Journal for Immunotherapy of Cancer, 2022, 10 (1), pp.e003687. ⟨10.1136/jitc-2021-003687⟩ Article dans une revue hal-03583256v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer François Bertucci , Pascal Finetti , Ines Simeone , Wouter Hendrickx , Ena Wang , et al. British Journal of Cancer, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩ Article dans une revue hal-03606514v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites Emilie Mamessier , Charlotte Drevet , Florence Broussais-Guillaumot , Marie-Laure Mollichella , Sylvain Garciaz , et al. Haematologica, 2015, 100, pp.E155-E157 Article dans une revue hal-01216319v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter Bernadette de Rauglaudre , Pascal Finetti , David Jérémie Birnbaum , Marc Lopez , François Bertucci , et al. Molecular Cancer Therapeutics, 2022, 21 (11), pp.1742-1743. ⟨10.1158/1535-7163.MCT-22-0240⟩ Article dans une revue hal-03958336v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Comparison of Induced Sputum and Bronchoalveolar Lavage in Lung Transplant Recipients François Bertucci , Pascal Finetti , Nathalie Cervera , Emmanuelle Charafe-Jauffret , José Adélaïde , et al. The Journal of Heart and Lung Transplantation, 2006, 25 (5), pp.523-532. ⟨10.1016/j.healun.2005.12.009⟩ Article dans une revue hal-03583497v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Prognostic Value of Molecular Subtypes in Pancreatic Cancer François Bertucci , David Birnbaum , Pascal Finetti , Marine Gilabert , Flora Poizat , et al. Pancreas, 2017, 46 (4), pp.e29-e31. ⟨10.1097/MPA.0000000000000787⟩ Article dans une revue hal-03606452v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response Stephanie Yerkovich , Marjut Roponen , Miranda Smith , Kathy Mckenna , Anthony Bosco , et al. Journal of Allergy and Clinical Immunology, 2009, 123 (1), pp.209 - 216.e4. ⟨10.1016/j.jaci.2008.09.009⟩ Article dans une revue istex hal-01765661v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A 25-gene classifier predicts overall survival in resectable pancreatic cancer David Birnbaum , Pascal Finetti , Alexia Lopresti , Marine Gilabert , Flora Poizat , et al. BMC Medicine, 2017, 15 (1), ⟨10.1186/s12916-017-0936-z⟩ Article dans une revue hal-01787872v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Les granules de stress, des acteurs émergents en cancérologie Pauline Chavrier , Emilie Mamessier , Anaïs Aulas Médecine/Sciences, 2021, 37 (8-9), pp.735-741. ⟨10.1051/medsci/2021109⟩ Article dans une revue hal-03606423v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency B. Neven , Emilie Mamessier , Julien Bruneau , S. Kaltenbach , D. Kotlarz , et al. Blood, 2013, 122 (23), pp.3713 - 3722. ⟨10.1182/blood-2013-06-508267⟩ Article dans une revue hal-01765647v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer François Bertucci , Alexandre de Nonneville , Pascal Finetti , Emilie Mamessier Cancer Communications, 2023, 43 (8), pp.943-946. ⟨10.1002/cac2.12447⟩ Article dans une revue hal-04390884v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis Alexandre de Nonneville , Pascal Finetti , Emilie Mamessier , François Bertucci JNCI: Journal of the National Cancer Institute, 2022, ⟨10.1093/jnci/djac031⟩ Article dans une revue hal-03583244v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Kinome expression profiling and prognosis of basal breast cancers. Renaud Sabatier , Pascal Finetti , Emilie Mamessier , Stéphane Raynaud , Nathalie Cervera , et al. Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩ Article dans une revue inserm-00614833v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Cellules tumorales circulantes : au cœur de la plasticité tumorale Alexia Lopresti , Claire Acquaviva , Daniel Birnbaum , Emilie Mamessier Médecine/Sciences, 2017, 33 (5), pp.491 - 493. ⟨10.1051/medsci/20173305011⟩ Article dans une revue hal-01787274v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer Yuchen Guo , Monica Gabola , Rossano Lattanzio , Conception Paul , Valérie Pinet , et al. Journal of Clinical Investigation, 2021, 131 (4), ⟨10.1172/JCI131517⟩ Article dans une revue hal-03152320v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease Roxane Mari , Emilie Mamessier , Eric Lambaudie , Magali Provansal , Daniel Birnbaum , et al. Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩ Article dans une revue hal-03606425v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts J. Gertner-Dardenne , R. Castellano , Emilie Mamessier , S. Garbit , E. Kochbati , et al. Journal of Immunology, 2012, 188 (9), pp.4701 - 4708. ⟨10.4049/jimmunol.1103710⟩ Article dans une revue hal-01765650v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Early Steps of Follicular Lymphoma Pathogenesis Sandrine Roulland , Mustapha Faroudi , Emilie Mamessier , Stéphanie Sungalee , Gilles Salles , et al. Advances in Immunology, 111, Elsevier, pp.1-46, 2011, Advances in Immunology, ⟨10.1016/B978-0-12-385991-4.00001-5⟩ Chapitre d'ouvrage hal-03606472v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer Francois Bertucci , Pascal Finetti , Ines Simeone , Wouter Hendrickx , Ena Wang , et al. Breast Cancer Research and Treatment, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩ Article dans une revue hal-02143596v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Assessment of T lymphocyte cytokine production in induced sputum from asthmatics: a flow cytometry study S. Boniface , V. Koscher , Emilie Mamessier , M. El Biaze , P. Dupuy , et al. Clinical & Experimental Allergy, 2003, 33 (9), pp.1238-1243. ⟨10.1046/j.1365-2222.2003.01762.x⟩ Article dans une revue istex hal-03606407v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors David Birnbaum , François Bertucci , Pascal Finetti , Daniel Birnbaum , Emilie Mamessier Cancers, 2019, 11 (4), pp.497. ⟨10.3390/cancers11040497⟩ Article dans une revue hal-03583447v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer Alice Mogenet , Pascal Finetti , Emilie Denicolai , Laurent Greillier , Pascaline Boudou-Rouquette , et al. Journal of Translational Medicine, 2023, 21 (1), pp.637. ⟨10.1186/s12967-023-04463-2⟩ Article dans une revue hal-04390901v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial Renaud Sabatier , Cécile Vicier , Séverine Garnier , Arnaud Guille , Nadine Carbuccia , et al. Annals of Oncology, 2021, 32 (15_suppl), pp.S737-S738. ⟨10.1016/j.annonc.2021.08.1181⟩ Article dans une revue hal-03622737v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia. Audrey Benyamine , A. Le Roy , Emilie Mamessier , J. Gertner-Dardenne , C. Castanier , et al. OncoImmunology, 2016, ⟨10.1080/2162402X.2016.1146843⟩ Article dans une revue inserm-01416288v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Prognostic value of PDL1 expression in pancreatic cancer David Birnbaum , Pascal Finetti , Alexia Lopresti , Marine Gilabert , Flora Poizat , et al. Oncotarget, 2016, 7 (44), pp.71198-71210. ⟨10.18632/oncotarget.11685⟩ Article dans une revue hal-03583475v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response Laurys Boudin , A de Nonneville , Pascal Finetti , Léna Mescam , A Le Cesne , et al. Journal of Translational Medicine, 2022, 20 (1), pp.464. ⟨10.1186/s12967-022-03679-y⟩ Article dans une revue hal-03958345v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Low cholesterol biosynthesis favors epithelial‐to‐mesenchymal transition maintenance and influences tumor molecular subtyping and disease‐free survival in colon cancer patients Anaïs Aulas , Maria Lucia Liberatoscioli , Pascal Finetti , Olivier Cabaud , David Birnbaum , et al. Cancer Communications, 2022, 42 (8), pp.793-797. ⟨10.1002/cac2.12329⟩ Article dans une revue hal-03765661v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 François Bertucci , Alexandre de Nonneville , Pascal Finetti , Emilie Mamessier JNCI: Journal of the National Cancer Institute, 2023, 115 (6), pp.762-763. ⟨10.1093/jnci/djad060⟩ Article dans une revue hal-04390880v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		The MonarchE trial: improving the clinical outcome in HR + /HER2 − early breast cancer: recent results and next steps François Bertucci , Pascal Finetti , Emilie Mamessier , Alexandre de Nonneville Cancer Communications, 2023, 43 (8), pp.938-942. ⟨10.1002/cac2.12466⟩ Article dans une revue hal-04390900v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More

Filtrer vos résultats

Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites

First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter

Comparison of Induced Sputum and Bronchoalveolar Lavage in Lung Transplant Recipients

Prognostic Value of Molecular Subtypes in Pancreatic Cancer

Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response

A 25-gene classifier predicts overall survival in resectable pancreatic cancer

Les granules de stress, des acteurs émergents en cancérologie

A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer

RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis

Kinome expression profiling and prognosis of basal breast cancers.

Cellules tumorales circulantes : au cœur de la plasticité tumorale

Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts

Early Steps of Follicular Lymphoma Pathogenesis

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

Assessment of T lymphocyte cytokine production in induced sputum from asthmatics: a flow cytometry study

Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.

Prognostic value of PDL1 expression in pancreatic cancer

CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response

Low cholesterol biosynthesis favors epithelial‐to‐mesenchymal transition maintenance and influences tumor molecular subtyping and disease‐free survival in colon cancer patients

RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1

The MonarchE trial: improving the clinical outcome in HR + /HER2 − early breast cancer: recent results and next steps